Back to Journals » Infection and Drug Resistance » Volume 1

Characterization and antibiotic susceptibility of Listeria monocytogenes isolated from poultry and red meat in Morocco

Authors Hayat Ennaji, Mohammed Timinouni, My Mustapha Ennaji, Mohammed Hassar, Nozha Cohen

Published 28 September 2008 Volume 2008:1 Pages 45—50

DOI https://doi.org/10.2147/IDR.S3632

Review by Single-blind

Peer reviewer comments 1

Hayat Ennaji1,2, Mohammed Timinouni2, My Mustapha Ennaji3, Mohammed Hassar1, Nozha Cohen1

1Laboratoire de Microbiologie et Hygiène des Aliments et de l’Environnement, Institut Pasteur du Maroc., Casablanca, Morocco; 2Laboratoire de Microbiologie et Biologie Moléculaire, Institut Pasteur du Maroc., Casablanca, Morocco; 3Laboratoire de Virologie et Hygiène and Microbiologie., Faculté des Sciences et Techniques - Mohammedia, Université Hassan II, Mohammedia, Morocco

Abstract: This study was carried out on 426 samples of raw meats collected from butcheries and supermarkets in Casablanca, Morocco. The samples were examined for the occurrence of Listeria species. Strains of Listeria monocytogenes were characterized by several biochemical tests and confirmed by polymerase chain reaction (PCR). β-hemolytic cultures and nonhemolytic isolates were tested for biochemical properties with the Listeria API test. Among the 43 Listeria species isolates; we identified 10 strains for L. monocytogenes (23.3%), 31 strains for L. innocua (72.1%) and 2 strains for L. welshimeri (4.6%). Strains of L. monocytogenes were separated by multiplex PCR; two serogroups IIb and IVb were thus differentiated. Antibiotic susceptibility of L. monocytogenes to 21 antibiotics was determined by the disk diffusion method. All isolates were susceptible to a wide range of the tested antibiotics with the exception of nalidixic acid, colistine and cephalosporins second and third generation for which they were all resistant.

Keywords: antibiotic susceptibility, Listeria monocytogenes, meat, PCR

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy

Graff JN, Chamberlain ED

Core Evidence 2015, 10:1-10

Published Date: 18 December 2014

Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis

Dookie N, Sturm AW, Moodley P

Infection and Drug Resistance 2014, 7:223-228

Published Date: 19 August 2014

Management strategies in the treatment of neonatal and pediatric gastroenteritis

Ciccarelli S, Stolfi I, Caramia G

Infection and Drug Resistance 2013, 6:133-161

Published Date: 29 October 2013

Emerging therapies for Clostridium difficile infection – focus on fidaxomicin

Chaparro-Rojas F, Mullane KM

Infection and Drug Resistance 2013, 6:41-53

Published Date: 28 June 2013

Current management options for latent tuberculosis: a review

Norton BL, Holland DP

Infection and Drug Resistance 2012, 5:163-173

Published Date: 29 November 2012

Adverse incidents resulting in exposure to body fluids at a UK dental teaching hospital over a 6-year period

Hughes A, Davies L, Hale R, Gallagher JE

Infection and Drug Resistance 2012, 5:155-161

Published Date: 25 October 2012

A necrotic lung ball caused by co-infection with Candida and Streptococcus pneumoniae

Yokoyama T, Sasaki J, Matsumoto K, Koga C, Ito Y, Kaku Y, Tajiri M, Natori H, Hirokawa M

Infection and Drug Resistance 2011, 4:221-224

Published Date: 15 December 2011

Current and novel antibiotics against resistant Gram-positive bacteria

Federico Perez, Robert A Salata, Robert A Bonomo

Infection and Drug Resistance 2008, 1:27-44

Published Date: 9 September 2008